Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Familial glucocorticoid deficiency type 1 (FGD1) is an autosomal recessive disorder caused by biallelic loss-of-function variants in MC2R, the ACTH receptor expressed in the adrenal cortex. Affected individuals present with low or undetectable serum cortisol, markedly elevated ACTH, hypoglycemia, seizures, skin hyperpigmentation, hyperbilirubinemia, cholestasis, and tall stature, often with dysmorphic features such as hypertelorism, prominent forehead, and a broad nasal bridge ([PMID:31244773]).
MC2R-associated FGD1 follows an autosomal recessive inheritance pattern with extensive genetic heterogeneity. To date, 107 probands (85 homozygotes, 21 compound heterozygotes, 1 heterozygote) have been reported carrying 59 distinct MC2R variants ([PMID:32952553]). Segregation of a novel homozygous c.326T>A (p.Leu109Gln) variant in two siblings confirmed recessive inheritance ([PMID:35506146]). Additionally, five Arab kindreds share a recurrent c.459dupC (p.Ile154HisfsTer?) frameshift variant ([PMID:21778684]).
The MC2R variant spectrum comprises predominantly missense changes with additional frameshift/nonsense, splice-site, and a non-coding promoter deletion. In aggregate, 50 missense, 6 frameshift/nonsense, 3 splice, and 1 large promoter deletion variants have been documented in FGD1 ([PMID:32952553]). No widely distributed founder alleles have been identified outside consanguineous populations.
Functional studies demonstrate a loss-of-function mechanism via defective receptor folding, trafficking, or signaling. In vitro expression of p.Ser74Ile and p.Pro273His in melanoma cells showed markedly reduced cAMP responses to ACTH, confirming impaired signal transduction ([PMID:9758716]). Luciferase reporter assays in ACTH-unresponsive OS-3 cells revealed negligible activity for R137W, p.Tyr254Cys, and other mutants, establishing functional concordance with human phenotypes ([PMID:12213892]). Co-expression with MRAP rescues membrane localization for select variants, underscoring its role in MC2R trafficking.
Rare activating or regulatory variants do not dispute the MC2R–FGD1 association but illustrate receptor regulation complexity. A double mutant p.Cys21Arg/p.Ser247Gly exhibited constitutive cAMP signaling in Y6 cells without clinical hypercortisolism ([PMID:15062562]). A promoter polymorphism (CCC/CCC) reduces ACTH responsiveness in healthy subjects, highlighting regulatory elements outside coding regions ([PMID:15240582]).
In summary, MC2R mutations have a definitive association with FGD1, supported by extensive genetic and functional evidence. Molecular diagnosis of MC2R variants enables targeted hydrocortisone replacement, prevents life-threatening hypoglycemic crises, and informs family counseling.
Gene–Disease AssociationDefinitive107 probands across diverse populations, multi-family segregation, concordant functional data Genetic EvidenceStrong107 probands with 59 distinct MC2R variants in AR segregation from multiple families Functional EvidenceModerateMultiple in vitro assays demonstrate loss of receptor trafficking and cAMP signaling for pathogenic MC2R variants |